Supriya Lifescience Profit & Loss Annual

BSE: 543434 | NSE: SUPRIYA | ISIN: INE07RO01027 | Sector: Biotechnology & Drugs

855.20 +12.60 (1.50%)Updated : 04 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	562.69	456.13	413.16	343.77
Other Net	11.49	-1.10	0.76	-1.43
Diluted Weighted Average Shares	8.05	8.05	8.05	8.05
Depreciation/ Amortization	28.41	20.44	15.82	11.82
Operating Income	265.18	240.36	157.21	117.17
Net Income	209.12	187.96	119.11	89.86
Income Availableto Com Excl Extra Ord	209.12	187.96	119.11	89.86
Other Operating Expenses Total	183.12	3.45	2.03	2.29
Net Income Before Taxes	274.78	248.48	165.69	123.49
Net Income After Taxes	209.12	187.96	119.11	89.86
Income Availableto Com Incl Extra Ord	209.12	187.96	119.11	89.86
Costof Revenue Total	254.03	248.47	257.50	206.98
Gross Profit	573.85	448.01	312.87	253.96
Interest Inc( Exp) Net- Non- Op Total	-1.89	9.22	7.73	7.87
Unusual Expense( Income)	0.46	8.91	6.69	6.67
Diluted Net Income	209.12	187.96	119.11	89.86
DPS- Common Stock Primary Issue	1.00	1.00	0.80	0.60
Provisionfor Income Taxes	65.66	60.52	46.58	33.63
period Type	-	-	-	-
Net Income Before Extra Items	209.12	187.96	119.11	89.86
Total Revenue	827.88	696.49	570.37	460.94
period Length	12.00	12.00	12.00	12.00
Revenue	827.88	696.49	570.37	460.94
Selling/ General/ Admin Expenses Total	96.68	170.80	130.03	114.77
Diluted Normalized EPS	26.02	24.19	15.40	11.78
Diluted EPS Excluding Extra Ord Items	25.98	23.35	14.80	11.16
Total Adjustmentsto Net Income	-	0.01	-	-
Gain( Loss)on Saleof Assets	-	-0.01	0.00	-0.11
Research Development	-	4.05	1.09	1.24

*All figures in crores except per share values

Trending Stocks

1,266.15+11.15(0.89%)

1,686.60+13.70(0.82%)

2,540.00+13.30(0.53%)

4,960.00-110.00 (-2.17%)

2,807.35-55.15 (-1.93%)

Related News